Towards understanding the role of nanomedicine in targeting TNFR2 in rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the synovium and progressive joint destruction which significantly affects both quality of life and socioeconomic status. Admittedly, various treatments are available, but they are usually accompanied by vario...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Immunology Ročník 173; číslo 4; s. 622 - 633
Hlavní autoři:	Lambuk, Fatmawati, Nordin, Nor Asyikin, Mussa, Ali, Lambuk, Lidawani, Ahmad, Suhana, Hassan, Rosline, Kadir, Ramlah, Mohamud, Rohimah, Yahya, Nurul Khaiza
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Wiley Subscription Services, Inc 01.12.2024
Témata:	Animals Antirheumatic Agents - therapeutic use Apoptosis Arthritis Arthritis, Rheumatoid - drug therapy autoimmune disease Autoimmune diseases Control equipment Drug development Health services Humans Inflammation Molecular Targeted Therapy Nanomedicine - methods Nanoparticles Nanoparticles - therapeutic use Nanotechnology Necroptosis Pathophysiology Precision medicine Quality of life Receptors, Tumor Necrosis Factor, Type II - antagonists & inhibitors Receptors, Tumor Necrosis Factor, Type II - metabolism Rheumatoid arthritis Rheumatoid synovitis Side effects Signal Transduction - drug effects Socioeconomics Tumor necrosis factor Tumor necrosis factor receptors Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - metabolism Tumor necrosis factor-TNF tumour necrosis factor receptor 2 (TNFR2) tumour necrosis factor‐alpha (TNF‐α) nanoparticles autoimmune disease rheumatoid arthritis tumour necrosis factor receptor 2 (TNFR2) tumour necrosis factor‐alpha (TNF‐α) tumour necrosis factor-alpha (TNF-alpha)
ISSN:	0019-2805, 1365-2567, 1365-2567
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!